financetom
Business
financetom
/
Business
/
Uber fined in Netherlands for sending drivers' data to the US
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Uber fined in Netherlands for sending drivers' data to the US
Aug 26, 2024 1:19 AM

AMSTERDAM, Aug 26 (Reuters) - Ride-hailing platform Uber ( UBER )

has been fined 290 million euros ($324 million) in the

Netherlands for sending the personal data of European taxi

drivers to the United States in violation of EU rules, Dutch

data protection watchdog DPA said on Monday.

Uber ( UBER ) has stopped the practice, DPA added.

"This flawed decision and extraordinary fine are completely

unjustified. Uber's ( UBER ) cross-border data transfer process was

compliant with GDPR during a 3-year period of immense

uncertainty between the EU and U.S.. We will appeal and remain

confident that common sense will prevail," Uber ( UBER ) spokesperson

Caspar Nixon told Reuters in an email.

"Uber ( UBER ) transferred personal data of European taxi drivers to

the United States and failed to appropriately safeguard the

data," the DPA said

"This constitutes a serious violation of the General Data

Protection Regulation (GDPR)," it said.

The investigation was triggered by a complaint from French

taxi drivers.

French national data protection regulator CNIL said in a

separate statement that it had cooperated with its peer in the

Netherlands where Uber ( UBER ) has its main European base.

($1 = 0.8942 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Block Plans $1.5 Billion Senior Notes Offering
Block Plans $1.5 Billion Senior Notes Offering
May 6, 2024
08:18 AM EDT, 05/06/2024 (MT Newswires) -- Block (SQ) said Monday it plans a private placement of $1.5 billion in senior notes. The company and the purchasers have yet to set the interest rate, redemption provisions, maturity date, and other terms of the notes. Block intends to use the net proceeds from this offering for general corporate purposes, which may...
Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition
Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition
May 6, 2024
May 6 (Reuters) - Gossamer Bio ( GOSS ) said on Monday it will collaborate with Italian drugmaker Chiesi Group to develop and commercialize its therapy seralutinib in multiple indications related to high blood pressure due to constriction of lung arteries. The therapy is currently in late-stage development for the treatment of pulmonary arterial hypertension (PAH), which affects about 40,000...
Spectral Medical Says 105 Patients Now Enrolled in Tigris Trial
Spectral Medical Says 105 Patients Now Enrolled in Tigris Trial
May 6, 2024
08:16 AM EDT, 05/06/2024 (MT Newswires) -- Spectral Medical ( EDTXF ) , which is advancing therapeutic options for sepsis and septic shock, on Monday provided an update on its Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion (PMX) in a trial of adults treated for endotoxemia and septic shock. The company reports that...
LSL Pharma to Acquire Quebec Competitor for $2.5 Million to Expand Natural-Product Offerings
LSL Pharma to Acquire Quebec Competitor for $2.5 Million to Expand Natural-Product Offerings
May 6, 2024
08:18 AM EDT, 05/06/2024 (MT Newswires) -- LSL Pharma Group ( LPGIF ) on Monday said it will acquire a rival pharmaceutical manufacturer for $2.5 million in cash to expand its contract-manufacturing of natural health products. LSL identified the company only as a Quebec-based competing contract drug manufacturer (CDMO) specialized in the formulation, production, and marketing of natural products. LSL...
Copyright 2023-2026 - www.financetom.com All Rights Reserved